Back to Search
ANDREW LASSMAN, MD
MD
Neurology Physician
NPI: 1336110378IndividualAccepts Medicare
Specialties, Licenses & Credentials
Neurology PhysicianPrimary
Psychiatry & Neurology — Neurology
Code: 2084N0400X
210850(NY)
CMS Specialties
PrimaryNEUROLOGY
Education
COLUMBIA UNIVERSITY COLLEGE OF PHYSICIANS AND SURGEONS
Class of 1997
Research & Publications (20)
Should patients with anaplastic oligodendroglial tumors receive adjuvant chemotherapy?
PMID 17228307·Nat Clin Pract Oncol·2007
8-other
Incorporating molecular tools into clinical trials and treatment for gliomas?
PMID 17992094·Curr Opin Neurol·2007
6-review
Systemic high-dose intravenous methotrexate for central nervous system metastases.
PMID 16344918·J Neurooncol·2006
3-trial
Molecular study of malignant gliomas treated with epidermal growth factor receptor inhibitors: tissue analysis from North American Brain Tumor Consortium Trials 01-03 and 00-01.
PMID 16278407·Clin Cancer Res·2005
3-trial
Paroxysmal apnea and vasomotor instability following medullary infarction.
PMID 16087770·Arch Neurol·2005
5-case
Overexpression of c-MYC promotes an undifferentiated phenotype in cultured astrocytes and allows elevated Ras and Akt signaling to induce gliomas from GFAP-expressing cells in mice.
PMID 17047730·Neuron Glia Biol·2004
8-other
Phase II trials of erlotinib or gefitinib in patients with recurrent meningioma.
PMID 19562255·J Neurooncol·2010
3-trial
Randomized phase II trial of chemoradiotherapy followed by either dose-dense or metronomic temozolomide for newly diagnosed glioblastoma.
PMID 19506159·J Clin Oncol·2009
3-trial
Molecular profiling of oligodendrogliomas: impact on prognosis, treatment, and future directions.
PMID 19080743·Curr Oncol Rep·2009
6-review
A pilot study of everolimus and gefitinib in the treatment of recurrent glioblastoma (GBM).
PMID 19018475·J Neurooncol·2009
3-trial
A phase II trial of vinorelbine and intensive temozolomide for patients with recurrent or progressive brain metastases.
PMID 17987262·J Neurooncol·2008
3-trial
Myelosuppression in patients benefiting from imatinib with hydroxyurea for recurrent malignant gliomas.
PMID 17594055·J Neurooncol·2007
3-trial
Survey of treatment recommendations for anaplastic oligodendroglioma.
PMID 17435180·Neuro Oncol·2007
8-other
Glioma oncogenesis and animal models of glioma formation.
PMID 17113459·Hematol Oncol Clin North Am·2006
7-preclinical
Unraveling molecular markers of biologic therapies in glioma.
PMID 16635425·Curr Neurol Neurosci Rep·2006
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 710 W 168TH ST
NEW YORK, NY 10032 - Phone
- (212) 342-0571
Quick Facts
- NPI
- 1336110378
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 29
- Publications
- 20
Are you this provider?
Claim Your Profile